Pediatric High Grade Glioma Classification Criteria and Molecular Features of a Case Series
Pediatric high-grade gliomas (pHGGs) encompass a heterogeneous group of tumors. Three main molecular types (<i>H3.3</i> mutant, <i>IDH</i> mutant, and <i>H3.3/IDH</i> wild-type) and a number of subtypes have been identified. We provide an overview of pHGGs and pre...
Main Authors: | Anna Maria Buccoliero, Laura Giunti, Selene Moscardi, Francesca Castiglione, Aldesia Provenzano, Iacopo Sardi, Mirko Scagnet, Lorenzo Genitori, Chiara Caporalini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/13/4/624 |
Similar Items
-
Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
by: Barbara Castelli, et al.
Published: (2023-09-01) -
Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
by: Barbara Castelli, et al.
Published: (2024-02-01) -
Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas
by: Kanish Mirchia, et al.
Published: (2020-07-01) -
Implications of Concurrent <i>IDH1</i> and <i>IDH2</i> Mutations on Survival in Glioma—A Case Report and Systematic Review
by: Alexander Yuile, et al.
Published: (2022-10-01) -
Frequency of IDH1 mutation in adult-type diffuse astrocytic gliomas in a tertiary hospital in Kenya
by: Samuel Gakinya, et al.
Published: (2024-02-01)